A B S T R A C T Recent work suggests the existence of a dual corticosteroid feedback mechanism of stressinduced ACTH secretion in the rat. This possibility led us to study the kinetics of suppression of ACTH levels by corticosteroid administration in patients with nonstress ACTH hypersecretion secondary to hypoadrenocorticism. Cortisol was administered according to different protocols, which were chosen to provide extreme variations of the input signal. By this means, two phases of suppression ofACTH levels could be differentiated. A first decrease occurred without latency whenever, and as long as, plasma cortisol levels were rising. There was a linear regression between the logarithm of the increments in cortisol concentrations and the decrease in ACTH levels per minute (r = 0.951) (differential or rate-sensitive feedback mechanism). Neither the absolute doses of cortisol, nor plasma cortisol concentrations were closely correlated with the degree of suppression of ACTH by this rapid mechanism. A second decrease in ACTH levels began _30 min after corticosteroid administration. In this case there was a significant linear regression between the degree of inhibition of ACTH levels and the cortisol doses (r = 0.997) (integral or dose-sensitive feedback mechanism).
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The dose-sensitive feedback effects ofdexamethasone were less than might have been predicted from its relative anti-inflammatory potency. No rate-sensitive effects were seen with dexamethasone doses of 1 (3) (4) (5) (6) (7) (8) (9) . The first was brief and occurred immediately after the administration of the steroid: this has been designated as "fast feedback." It was characterized by rate sensitivity and saturability. The second period of inhibition of stress-induced ACTH release was much longer and did not occur until an hour or more after steroid administration. The second mechanism required larger doses than the first and the duration of inhibition was prolonged with increased dosage (proportionality). This feedback has, therefore, been called "level-sensitive, delayed feedback." The time in between these two periods was called the "silent period."
These concepts arose mostly from experiments in which the inhibition ofthe stress-induced ACTH secretion in rats was used to test the state of the hypothalamic-pituitary system. However, nonstress and stress-induced ACTH secretion may be dissociated on the basis of sensitivity to negative corticosteroid feedback effects (10) (11) (12) . Data from human subjects that bear on the topic of rate-sensitive feedback are scarce. These considerations led us to study the dynamics of suppression ofACTH levels by corticosteroids in patients with nonstress ACTH hypersecretion secondary to hypoadrenocorticism (primary adrenocortical insufficiency). Different experimental designs for administration of cortisol or dexarnethasone were chosen to provide extreme variations of the input signal, i.e. All studies were performed in the moming hours, starting between 8 and 9 a.m., 24 h after the last dose of the usual replacement therapy. None of the patients experienced any symptoms of corticosteroid withdrawal during this short period. Cortisol (100 mg free alcohol in 20 ml 50% ethyl alcohol; Hydrocortison zur Infusion, Hoechst AG, Frankfurt, West Germany) was administered intravenously according to different protocols: Protocol 1, constant rate infusion of 50 or 12.5 mg cortisol/h for 2 h, with a Braun perfusor; Protocol 2, infusion of 50 mg cortisol during 15 min at constant rate; Protocol 3, infusion of 50 mg cortisol during 5 min at constant rate; Protocol 4, bolus injection of 25 or 5 mg cortisol. It must be stated that 50-100 mg of cortisol is a large intravenous dose when the normal, adult human subject is considered to secrete about 20 mg of cortisol in 24 h. In some cases, dexamethasone-21-orthophosphate (Fortecortin-MonoAmpullen, Merck AG) was given intravenously, either at 1.25 mg/h at a constant rate for 2 h, or as a brief infusion of 1 mg during 15 min. Dexamethasone doses were chosen with respect to their anti-inflammatory potencies; dexamethasone was considered to be 30 times more potent than cortisol (13) . Venous blood was drawn from the arm through an indwelling cannula, at 5-or 15-min intervals, for determination of plasma ACTH levels.
Plasma-ACTH was estimated by radioimmunoassay after extraction of ACTH from the plasma as previously described (14, 15) . Starting ACTH levels in all patients 24 h after the last ingestion of corticosteroids were markedly elevated (1,450.5±334.3 pg/ml; mean±SEM; normal range 0-150 pg/ ml). Because of the large variations of the starting levels, all values have been calculated as percent of the individual mean base line. Plasma-cortisol measurements were performed by competitive protein-binding assay (16) .
Statistical methods (17) . To describe the time-course of ACTH levels in response to corticosteroids, two neighboring points of each curve were selected and tested by Student's t test for paired data. As only these segments of the curves were important for generating a hypothesis, it was not attempted to describe the whole curves by statistical analysis. To analyse the relationship between corticosteroids and ACTH levels, a regression analysis was performed for all ACTH values 15 and 75 min after cortisol administration and the corresponding cortisol doses, cortisol concentrations, and changes in cortisol concentrations, respectively.
RESULTS
The amounts ofalcohol necessary in these experiments for dissolution of cortisol were shown to be without effects on ACTH plasma levels. In six patients who received vehicle only, ACTH level varied considerably; however, on the average, there was a continuous slight decrease in normalized levels from 100%, initially, to 80.2 +6.6% (mean+ SEM) at the end ofthe second hour.
When cortisol was infused intravenously at constant rate for 2 h (Protocol 1), there was an immediate and rapid decrease in ACTH levels, which continued throughout the observation period (Fig. 1) (Fig. 4) . Plasma cortisol levels were extremely high during this time and still 70+9 ,ug/100 ml (mean±SEM) at the 15th min. By 30 min, a continuous decrease in ACTH levels had begun. With 5 mg cortisol given as a bolus, a similar time course of ACTH levels was observed (data not shown). The failure of bolus injections to suppress ACTH levels within 15 min was especially impressive when compared with the significant inhibition observed with Protocol 1 (50 mg cortisol/h) after 15 min. In this case, only 12.5 mg cortisol had been infused during this time and cortisol levels had just reached 40+5 ,ug/100 ml (mean+SEM) at the-end ofthis period.
From the findings described above, the following hypothesis was generated: After administration of cortisol to patients with Addison's disease, two phases of inhibition of ACTH secretion must be differentiated. A first decline in plasma ACTH levels occurred without delay whenever, and as long as, cortisol levels were tocol (r = 0.997; 2a < 0.001) (Fig. 6 ). There was a poor correlation to cortisol concentrations at 75 min (r = 0.855; 2a > 0.05) and obviously no correlation to the rates of changes in cortisol concentration. In Fig. 7 , the effects of dexamethasone (1 mg/15 min) on ACTH levels are demonstrated. There were no definite effects on ACTH levels during the first 15 min. An almost identical time course of ACTH levels was observed with infusion of 1.25 mg dexamethasone/h at a constant rate (data not shown). Apparently, these doses of dexamethasone did not suffice to activate ratesensitive feedback elements. When the inhibition observed at 75 min, was compared with that obtained with different doses of cortisol, it appeared that 1 mg dexamethasone caused about the same dose-sensitive inhibition of ACTH levels as did 15 mg cortisol. Dexamethasone is believed to be 30 times more potent, by anti-inflammatory effectiveness, than cortisol. Thus, by dose-sensitive feedback potency, the two corticosteroids differed less than might have been predicted. - (3) (4) (5) (6) (7) (8) (9) . In these experiments, there was a silent period of at least 1 h between the two phases of inhibition. The absence of a silent period in our experiments may be because nonstress and stress-induced ACTH secretion are dissociated on the basis of sensitivity to negative corticosteroid feedback effects (10) (11) (12) . In more recent experiments, corticosteroid feedback mechanisms were investigated at the hypothalamic level with the technique of the rat hypothalamus in vitro (18, 19) ; both fast and delayed feedback effects on secretion of corticotropin-releasing factor were demonstrated with doses of corticosteroids within, or near, the physiologic range. The results suggested that the fast feedback mechanism acted via the inhibition of release, whereas the delayed feedback mechanism acted via inhibition of both synthesis and release. Sato et al. (20) reached a similar conclusion based on in vivo studies. These findings provide a possible explanation for the paradoxical overshoot in ACTH levels immediately after cessation of the corticosteroid infusion in our experiments. During the period of rapid feedback, corticotropin-releasing factor could have accumulated in the hypothalamus. When the rapid feedback mechanism stopped and the delayed feedback mechanism was not yet effective, more corticotropin-releasing factor was available to induce an increase in ACTH levels.
Corticosteroid Feedback Mechanism of ACTH Secretion
The anti-inflammatory potency of dexamethasone is 30 times greater than that of cortisol in human beings (13) . In our experience, a dose of dexamethasone equipotent to 30 mg cortisol had no significant rate-sensitive feedback effects on ACTH secretion, and the dosesensitive feedback effects were less than expected from the relative potency. The great potency of dexamethasone as an inhibitor of ACTH release may be revealed only by studying the duration of inhibition. Yates and Maran (21) found that dexamethasone failed completely to inhibit ACTH release when it was given to rats from 15 s to a few minutes before a stressor. Dexamethasone-21-phosphate, used by these authors and by us, is more water soluble than is corticosterone, so it may not enter cells as rapidly as does the natural corticosteroid, which dissolves readily in lipid components of cell membranes. In these experiments, dexamethasone had to be given 1-2 h before a stressor to reveal its great inhibitory potency. On the other hand, Jones and Hillhouse (19) classified dexamethasone as an agonist of fast feedback with the hypothalamus in vitro.
Recently, we could demonstrate that in patients who have been totally adrenalectomized for treatment of Cushing's disease (hypercortisolism secondary to inappropriate ACTH secretion by the pituitary) infusion of cortisol induced a paradoxical rise in plasma ACTH levels of _400% (22) . This rise occurred only during the first 15 min ofan infusion of50 mg/h cortisol. Later, ACTH levels decreased, but did not fall far below starting levels. A more detailed examination of feedback effects of cortisol on ACTH secretion with similar protocols as in this study may provide a better understanding of the disturbance of the corticosteroid feedback mechanism characteristic for Cushing's disease.
Finally, we want to point out that rate sensitivity is a common property of many biological systems. Unidirectional rate sensitivity was first discovered in a number of biological reflex systems as described by Clynes (23) . There are striking similarities to the derivative and static mechanisms for insulin infusion, which are necessary to normalize glucose concentrations in diabetics by artificial beta cell (24, 25) .
